| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |